Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study.
von Bardeleben RS, Mahoney P, Morse MA, Price MJ, Denti P, Maisano F, Rogers JH, Rinaldi M, De Marco F, Rollefson W, Chehab B, Williams M, Leurent G, Asch FM, Rodriguez E. von Bardeleben RS, et al. Among authors: morse ma. JACC Cardiovasc Interv. 2023 Nov 13;16(21):2600-2610. doi: 10.1016/j.jcin.2023.09.029. Epub 2023 Oct 24. JACC Cardiovasc Interv. 2023. PMID: 37877913 Free article.
Expanding the Spectrum of TEER Suitability: Evidence From the EXPAND G4 Post Approval Study.
Rogers JH, Asch F, Sorajja P, Mahoney P, Price MJ, Maisano F, Denti P, Morse MA, Rinaldi M, Bedogni F, De Marco F, Rollefson W, Chehab B, Williams MR, Leurent G, Morikawa T, Asgar AW, Rodriguez E, von Bardeleben RS, Kar S. Rogers JH, et al. Among authors: morse ma. JACC Cardiovasc Interv. 2023 Jun 26;16(12):1474-1485. doi: 10.1016/j.jcin.2023.05.014. JACC Cardiovasc Interv. 2023. PMID: 37380229 Free article.
One-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation.
Zahr F, Smith RL, Gillam LD, Chadderdon S, Makkar R, von Bardeleben RS, Ruf TF, Kipperman RM, Rassi AN, Szerlip M, Goldman S, Inglessis-Azuaje I, Yadav P, Lurz P, Davidson CJ, Mumtaz M, Gada H, Kar S, Kodali SK, Laham R, Hiesinger W, Fam NP, Keßler M, O'Neill WW, Whisenant B, Kliger C, Kapadia S, Rudolph V, Choo J, Hermiller J, Morse MA, Schofer N, Gafoor S, Latib A, Mahoney P, Kaneko T, Shah PB, Riddick JA, Muhammad KI, Boekstegers P, Price MJ, Praz F, Koulogiannis K, Marcoff L, Hausleiter J, Lim DS; CLASP IID Pivotal Trial Investigators. Zahr F, et al. Among authors: morse ma. JACC Cardiovasc Interv. 2023 Oct 26:S1936-8798(23)01358-4. doi: 10.1016/j.jcin.2023.10.002. Online ahead of print. JACC Cardiovasc Interv. 2023. PMID: 37962288
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant.
Van Berckelaer C, Van Laere S, Lee S, Morse MA, Geradts J, Dirix L, Kockx M, Bertucci F, Van Dam P, Devi GR. Van Berckelaer C, et al. Among authors: morse ma. Transl Oncol. 2024 May;43:101907. doi: 10.1016/j.tranon.2024.101907. Epub 2024 Feb 27. Transl Oncol. 2024. PMID: 38412664 Free PMC article.
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma.
McIntyre SM, Preston WA, Walch H, Sharib J, Kundra R, Sigel C, Lidsky ME, Allen PJ, Morse MA, Chen W, Cercek A, Harding JJ, Abou-Alfa GK, O'Reilly EM, Park W, Balachandran VP, Drebin J, Soares KC, Wei A, Kingham TP, D'Angelica MI, Iacobuzio-Donahue C, Jarnagin WR. McIntyre SM, et al. Among authors: morse ma. JCO Precis Oncol. 2024 Feb;8:e2300534. doi: 10.1200/PO.23.00534. JCO Precis Oncol. 2024. PMID: 38394469
Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer.
Dailey GP, Rabiola CA, Lei G, Wei J, Yang XY, Wang T, Liu CX, Gajda M, Hobeika AC, Summers A, Marek RD, Morse MA, Lyerly HK, Crosby EJ, Hartman ZC. Dailey GP, et al. Among authors: morse ma. Hum Vaccin Immunother. 2024 Dec 31;20(1):2309693. doi: 10.1080/21645515.2024.2309693. Epub 2024 Feb 8. Hum Vaccin Immunother. 2024. PMID: 38330990 Free PMC article.
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032).
Callahan M, Amin A, Kaye FJ, Morse MA, Taylor MH, Peltola KJ, Sharma P, O'Reilly EM, Meadows Shropshire S, O'Brien S, Tschaika M, Le DT. Callahan M, et al. Among authors: morse ma. J Immunother Cancer. 2024 Feb 5;12(2):e007883. doi: 10.1136/jitc-2023-007883. J Immunother Cancer. 2024. PMID: 38316517 Free PMC article.
Mortality Associated With Proportionality of Secondary Mitral Regurgitation After Transcatheter Mitral Valve Repair: North American Mitraclip for Functional Mitral Regurgitation Registry.
Duggal NM, Engoren M, Chadderdon SM, Rodriguez E, Morse MA, Vannan MA, Yadav PK, Morcos M, Li F, Reisman M, Garcia-Sayan E, Raghunathan D, Sodhi N, Sorajja P, Chen L, Rogers JH, Calfon MA, Kovach CP, Gill EA, Zahr FE, Chetcuti SJ, Yuan Y, Mentz GB, Lim DS, Ailawadi G. Duggal NM, et al. Among authors: morse ma. Am J Cardiol. 2024 Feb 15;213:99-105. doi: 10.1016/j.amjcard.2023.12.020. Epub 2023 Dec 16. Am J Cardiol. 2024. PMID: 38110022
CEA vaccines.
Bhagat A, Lyerly HK, Morse MA, Hartman ZC. Bhagat A, et al. Among authors: morse ma. Hum Vaccin Immunother. 2023 Dec 15;19(3):2291857. doi: 10.1080/21645515.2023.2291857. Epub 2023 Dec 13. Hum Vaccin Immunother. 2023. PMID: 38087989 Free PMC article. Review.
398 results